Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Vergoeding CAR T-celtherapie liso-cel (Breyanzi) bij agressief lymfoom
mei 2024 | Lymfoom
okt 2020
apr 2020 | Transplantatie
apr 2020
jan 2020 | Leukemie